PARIS (MedPage Today) — The eyes are a window into the brain for many disorders, and Alzheimer’s disease may be no exception, a researcher said here.
Author: MedPage Today
Lazy Eye Tx Better in Younger Kids (CME/CE)
(MedPage Today) — Younger children with amblyopia respond better to treatment than do their older peers, a meta-analysis confirmed.
ADA: Anti-VEGF ‘Impressive’ in Sharpening Vision (CME/CE, with video)
SAN DIEGO (MedPage Today) — The good news continues to roll in for ranibizumab (Lucentis) in diabetic macular edema with positive RIDE and RISE trial results.
Glaucoma Drug Costs Up Strongly over Six Years (CME/CE)
(MedPage Today) — Spending on glaucoma medications increased 25% over the six-year period from 2001 through 2006, researchers reported.
Roundworms Carried by Pets Can Cause Blindness (CME/CE)
(MedPage Today) — Ocular toxocariasis, though rare, causes blindness in seven out of 10 of those affected by it, typically children, according to a national survey conducted by the CDC.
Lab Notes: Touch Restored, Blind Hear Images
(MedPage Today) — Three of the five senses — touch, sight, and hearing — are highlighted in this week’s Lab Notes, a round-up of intriguing, but not yet ready for prime time, research findings compiled by the MedPage Today staff.
Selenium Eases Graves’ Eye Symptoms (CME/CE)
(MedPage Today) — Selenium treatment of ocular symptoms in patients with Graves’ disease significantly improved their quality of life, European researchers found.
Eye Injury Visits More Common in Rural Areas
(MedPage Today) — Rural patients were five times more likely than their urban counterparts to visit a hospital emergency department with an eye injury, federal researchers reported.
ARVO: Novel VEGF Inhibitor Helps in AMD
(MedPage Today) — FORT LAUDERDALE, Fla. — An investigational drug for treating “wet” age-related macular degeneration (AMD) was as effective as ranibizumab (Lucentis) even when dosed every other month, two identical one-year studies showed.
ARVO: Once-Daily Glaucoma Drug Shows Promise
(MedPage Today) — An investigational, once-daily drug called tafluprost appears to lower intraocular pressure at least as well as a twice-daily glaucoma drug, researchers found.
ARVO: Two-Year Safety Equal in AMD Drug Trial
FORT LAUDERDALE (MedPage Today) — Preliminary two-year safety data from the landmark CATT trial of ranibizumab (Lucentis) and bevacizumab (Avastin) for macular degeneration partially reversed conclusions from the one-year results reported last week, s…
AMD Drug Study Sparks Concerns
(MedPage Today) — The study that put bevacizumab (Avastin) and ranibizumab (Lucentis) into a dead heat for treating “wet” age-related macular degeneration did not assure that the pricier drug would be out of contention or that the lower-cost one is a …
Lab Notes: Red Wine in a Stent
(MedPage Today) — The saga of red wine and heart disease has taken a surprising new turn, and a new study suggests that parts of a rat’s brain may take short naps even when the animal is awake — highlights of this week’s edition of Lab Notes.
Anti-VEGF Drug Trial Results in AMD Released Early (CME/CE)
(MedPage Today) — Full publication of results from the head-to-head study of bevacizumab (Avastin) and ranibizumab (Lucentis) in “wet” age-related macular degeneration has confirmed information previously leaked to the media — that the two drugs diff…
No Difference in Anti-VEGF Drugs for Wet AMD
(MedPage Today) — Researchers conducting a closely watched head-to-head study of intravitreal bevacizumab (Avastin) and ranibizumab (Lucentis) for slowing “wet” age-related macular degeneration (AMD) will report that the drugs were equally effective, …
Eyes May Be a Mirror of the Heart (CME/CE)
(MedPage Today) — Physical activity — or lack thereof — may be related to subclinical signs of cardiovascular risk in 6-year-olds, as indicated by changes in retinal microvasculature, researchers found.
Vitamin D Again Tied to Lower AMD Risk (CME/CE)
(MedPage Today) — Higher levels of circulating vitamin D appear to reduce the risk for early onset of age-related macular degeneration in women ages 50 to 74, an ancillary study of the Women’s Health Initiative showed.
AAAAI: Inhaled Steroid No Threat to Vision (CME/CE)
SAN FRANCISCO (MedPage Today) — The risk of cataracts among children with asthma on long-term inhaled budesonide is virtually nil, according to a study in which patients were on the steroid treatment for an average of 16 years.
Eyelid Surgery Boosts QOL in Facial Paralysis (CME/CE)
(MedPage Today) — For patients who couldn’t close their eyes because of facial paralysis, surgery produced a significant improvement in quality of life as well as in dryness and irritation, results of a small clinical study showed.
Strokes More Common With Retinal Condition (CME/CE)
(MedPage Today) — Stroke risk roughly doubles with retinal vein occlusion, but the risk of myocardial infarction did not appear higher, according to a retrospective analysis of a claims database.